Anocca has achieved regulatory approval for its first clinical trial, VIDAR-1, a major milestone in the company’s transition ...

“The collaboration with Dynamic42 has given us the opportunity to develop a state-of-the-art system that can significantly ...

Until now, no ideal single screening test exists for pancreatic cancer. A variety of tumor markers have been tested for the diagnosis of pancreatic cancer. The serum marker carbohydrate antigen 19 ...

Proposed NIH cuts cloud the future of cancer research in Oregon. "We are so close right now to these amazing discoveries, ...

Why is pancreatic cancer, in fact ... Dee Peterschmidt is a producer, host of the podcast Universe of Art, and composes music for Science Friday’s podcasts. Their D&D character is a clumsy bard named ...

Pancreatic cancer is a devastating disease with a median survival of approximately 6 months after diagnosis. Many factors are associated with a worse outcome; examples include late diagnosis, low ...

The biotech company Dynamic42, a specialist in organ-on-chip technology, has made a significant advance in pancreatic cancer ...

Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...

AID system powered by Tidepool expected to launch Q2 2025 in the U.S. with Abbott’s FreeStyle Libre® 3 Plus sensorMANCHESTER, N.H., March 18, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company ...

Angela ‘Angie’ Barmore Huso, a Calvert School staff member and Hunt Valley Presbyterian Church volunteer, died of pancreatic ...